Skip navigation
Skip navigation

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza

Hurt, Aeron C; Kelly, Heath

Description

A debate about the market-leading influenza antiviral medication, oseltamivir, which initially focused on treatment for generally mild illness, has been expanded to question the wisdom of stockpiling for use in future influenza pandemics. Although randomized controlled trial evidence confirms that oseltamivir will reduce symptom duration by 17-25 hours among otherwise healthy adolescents and adults with community-managed disease, no randomized controlled trials have examined the effectiveness...[Show more]

CollectionsANU Research Publications
Date published: 2016-06
Type: Journal article
URI: http://hdl.handle.net/1885/108947
Source: Emerging infectious diseases
DOI: 10.3201/eid2206.151037

Download

File Description SizeFormat Image
01_Hurt_Debate_Regarding_Oseltamivir_2016.pdf1.12 MBAdobe PDFThumbnail


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator